Molecular Neurosurgical Tissue Bank
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Brain Diseases
- Sponsor
- Vanderbilt University Medical Center
- Enrollment
- 2500
- Locations
- 1
- Primary Endpoint
- Tissue Used for Future Research Studies
- Status
- Enrolling By Invitation
- Last Updated
- last month
Overview
Brief Summary
The Molecular Neurosurgical Tissue Bank will function as a tissue or specimen repository for biopsy specimens from patients (both adult and pediatric) undergoing brain surgery and brain procedures.
Detailed Description
The Molecular Neurosurgical Tissue Bank will function as a tissue or specimen repository for biopsy specimens from patients (both adult and pediatric) undergoing brain surgery and brain procedures. Leftover tissue removed during the course of brain surgery will be collected and stored in neurosurgical laboratories for use in medical research that might be currently ongoing or for future research. In addition, blood and cerebral spinal fluid samples will also be collected and stored. Leftover cerebral spinal fluid (CSF) will be collected during standard of care procedures (lumbar punctures or ventricular drains) that take place at time of diagnosis, completion of therapy and relapse of disease or during neurosurgery. Blood will be drawn at time of routine lab draws required during the surgery or procedure.
Investigators
Reid Thompson
Director
Vanderbilt University Medical Center
Eligibility Criteria
Inclusion Criteria
- •Subjects having any type of brain surgery, where a specimen will be collected.
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Tissue Used for Future Research Studies
Time Frame: From enrollment until the end of study
Tissue collected through the study will be stored and used in future approved research studies